InvestorsObserver
×
News Home

Is Decibel Therapeutics Inc (DBTX) a Smart Choice in Biotechnology Tuesday?

Tuesday, August 22, 2023 10:01 AM | InvestorsObserver Analysts

Mentioned in this article

Is Decibel Therapeutics Inc (DBTX) a Smart Choice in Biotechnology Tuesday?

A rating of 77 puts Decibel Therapeutics Inc (DBTX) near the top of the Biotechnology industry according to InvestorsObserver. Decibel Therapeutics Inc's score of 77 means it scores higher than 77% of stocks in the industry. Decibel Therapeutics Inc also received an overall rating of 59, putting it above 59% of all stocks. Biotechnology is ranked 63 out of the 148 industries.

Overall Score - 59
DBTX has an Overall Score of 59. Find out what this means to you and get the rest of the rankings on DBTX!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 59 means the stock is more attractive than 59 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Decibel Therapeutics Inc Stock Today?

Decibel Therapeutics Inc (DBTX) stock is lower by -0.99% while the S&P 500 has risen 0.12% as of 9:33 AM on Tuesday, Aug 22. DBTX is lower by -$0.05 from the previous closing price of $5.06 on volume of 2,603 shares. Over the past year the S&P 500 is up 6.45% while DBTX has risen 18.72%. DBTX lost -$2.54 per share the over the last 12 months. Click Here to get the full Stock Report for Decibel Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App